Literature DB >> 33395700

Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion.

Song Yao1, Ting-Yuan David Cheng1,2, Ahmed Elkhanany3, Li Yan4, Angela Omilian1, Scott I Abrams5, Sharon Evans5, Chi-Chen Hong1, Qianya Qi4, Warren Davis1, Song Liu4, Elisa V Bandera6, Kunle Odunsi5, Kazuaki Takabe7, Thaer Khoury8, Christine B Ambrosone1.   

Abstract

BACKGROUND: Blacks tend to have a stronger inflammatory immune response than Whites. We hypothesized that racial differences in host immunity also manifest in the tumor microenvironment, constituting part of a distinct aggressive tumor biology underlying higher mortality in Black women.
METHODS: Pathological and gene expression profiling approaches were used for characterizing infiltrating immune cells in breast tumor microenvironment from 1315 patients from the Women's Circle of Health Study. Racial differences in tumor immune phenotypes were compared, with results validated in a publicly accessible dataset. Prognostic associations of immune phenotypes were assessed in 3 independent cohorts.
RESULTS: We found marked and consistent differences in tumor immune responses between Black and White patients. Not only did tumors from Blacks display a stronger overall immune presence but also the composition and quality of immune infiltrates differed, regardless of tumor subtypes. Black patients had a stronger CD4+ and B-cell response, and further, a more exhausted CD8+ T-cell profile. A signature indicating a higher ratio of exhausted CD8+ T cells to total CD8+ T cells (ExCD8-r) was consistently associated with poorer survival, particularly among hormone receptor-positive patients. Among hormone receptor-negative patients, combinations of the absolute fraction of CD8+ T cells and ExCD8-r signature identified the CD8lowExCD8-rhigh subgroup, the most prevalent among Blacks, with the worst survival.
CONCLUSIONS: Our findings of a distinct exhausted CD8+ T-cell signature in Black breast cancer patients indicate an immunobiological basis for their more aggressive disease and a rationale for the use of immune checkpoint inhibitors targeting the exhaustion phenotype.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2021        PMID: 33395700      PMCID: PMC8328978          DOI: 10.1093/jnci/djaa215

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  49 in total

1.  The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

Authors:  R Salgado; C Denkert; S Demaria; N Sirtaine; F Klauschen; G Pruneri; S Wienert; G Van den Eynden; F L Baehner; F Penault-Llorca; E A Perez; E A Thompson; W F Symmans; A L Richardson; J Brock; C Criscitiello; H Bailey; M Ignatiadis; G Floris; J Sparano; Z Kos; T Nielsen; D L Rimm; K H Allison; J S Reis-Filho; S Loibl; C Sotiriou; G Viale; S Badve; S Adams; K Willard-Gallo; S Loi
Journal:  Ann Oncol       Date:  2014-09-11       Impact factor: 32.976

2.  Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Authors:  Junko Matsuzaki; Sacha Gnjatic; Paulette Mhawech-Fauceglia; Amy Beck; Austin Miller; Takemasa Tsuji; Cheryl Eppolito; Feng Qian; Shashikant Lele; Protul Shrikant; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 3.  Understanding the tumor immune microenvironment (TIME) for effective therapy.

Authors:  Mikhail Binnewies; Edward W Roberts; Kelly Kersten; Vincent Chan; Douglas F Fearon; Miriam Merad; Lisa M Coussens; Dmitry I Gabrilovich; Suzanne Ostrand-Rosenberg; Catherine C Hedrick; Robert H Vonderheide; Mikael J Pittet; Rakesh K Jain; Weiping Zou; T Kevin Howcroft; Elisa C Woodhouse; Robert A Weinberg; Matthew F Krummel
Journal:  Nat Med       Date:  2018-04-23       Impact factor: 53.440

Review 4.  Breast cancer racial disparities: unanswered questions.

Authors:  Foluso O Ademuyiwa; Stephen B Edge; Deborah O Erwin; Heather Orom; Christine B Ambrosone; Willie Underwood
Journal:  Cancer Res       Date:  2010-12-06       Impact factor: 12.701

Review 5.  Molecular and cellular insights into T cell exhaustion.

Authors:  E John Wherry; Makoto Kurachi
Journal:  Nat Rev Immunol       Date:  2015-08       Impact factor: 53.106

6.  Tumor-Infiltrating Lymphocytes and Colorectal Cancer Survival in African American and Caucasian Patients.

Authors:  Kristin Wallace; David N Lewin; Shaoli Sun; Clayton M Spiceland; Don C Rockey; Alexander V Alekseyenko; Jennifer D Wu; John A Baron; Anthony J Alberg; Elizabeth G Hill
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-05-16       Impact factor: 4.254

7.  Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Authors:  Kathy S Albain; Joseph M Unger; John J Crowley; Charles A Coltman; Dawn L Hershman
Journal:  J Natl Cancer Inst       Date:  2009-07-07       Impact factor: 13.506

8.  Genetic ancestry and population differences in levels of inflammatory cytokines in women: Role for evolutionary selection and environmental factors.

Authors:  Song Yao; Chi-Chen Hong; Edward A Ruiz-Narváez; Sharon S Evans; Qianqian Zhu; Beverly A Schaefer; Li Yan; Marie V Coignet; Kathryn L Lunetta; Lara E Sucheston-Campbell; Kelvin Lee; Elisa V Bandera; Melissa A Troester; Lynn Rosenberg; Julie R Palmer; Andrew F Olshan; Christine B Ambrosone
Journal:  PLoS Genet       Date:  2018-06-07       Impact factor: 5.917

9.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

10.  Differences in the tumor microenvironment between African-American and European-American breast cancer patients.

Authors:  Damali N Martin; Brenda J Boersma; Ming Yi; Mark Reimers; Tiffany M Howe; Harry G Yfantis; Yien Che Tsai; Erica H Williams; Dong H Lee; Robert M Stephens; Allan M Weissman; Stefan Ambs
Journal:  PLoS One       Date:  2009-02-19       Impact factor: 3.240

View more
  16 in total

1.  APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival.

Authors:  Rongrong Wu; Masanori Oshi; Mariko Asaoka; Michelle R Huyser; Yoshihisa Tokumaru; Akimitsu Yamada; Li Yan; Itaru Endo; Takashi Ishikawa; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 2.  Immune response and inflammation in cancer health disparities.

Authors:  Maeve Kiely; Brittany Lord; Stefan Ambs
Journal:  Trends Cancer       Date:  2021-12-27

3.  The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.

Authors:  Melissa A Troester; Katherine A Hoadley; Alina M Hamilton; Amber N Hurson; Linnea T Olsson; Andrea Walens; Joseph Nsonwu-Farley; Erin L Kirk; Yara Abdou; Stephanie M Downs-Canner; Jonathan S Serody; Charles M Perou; Benjamin C Calhoun
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

4.  Bioinformatics methods in biomarkers of preeclampsia and associated potential drug applications.

Authors:  Ying Peng; Hui Hong; Na Gao; An Wan; Yuyan Ma
Journal:  BMC Genomics       Date:  2022-10-19       Impact factor: 4.547

Review 5.  Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research.

Authors:  Balaraman Kalyanaraman
Journal:  FASEB J       Date:  2022-04       Impact factor: 5.834

6.  Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.

Authors:  Vesal Yaghoobi; Myrto Moutafi; Thazin Nwe Aung; Vasiliki Pelekanou; Sanam Yaghoubi; Kim Blenman; Eiman Ibrahim; Ioannis A Vathiotis; Saba Shafi; Anup Sharma; Tess O'Meara; Aileen I Fernandez; Lajos Pusztai; David L Rimm
Journal:  Breast Cancer Res       Date:  2021-12-14       Impact factor: 6.466

7.  Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer.

Authors:  Sung Jun Ma; Lucas M Serra; Brian Yu; Mark K Farrugia; Austin J Iovoli; Han Yu; Song Yao; Oluwadamilola T Oladeru; Anurag K Singh
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.639

Review 8.  Race as a Contributor to Stromal Modulation of Tumor Progression.

Authors:  Mamatha Kakarla; Sathyavathi ChallaSivaKanaka; Simon W Hayward; Omar E Franco
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

9.  Multiplexed digital spatial profiling of invasive breast tumors from Black and White women.

Authors:  Angela R Omilian; Haiyang Sheng; Chi-Chen Hong; Elisa V Bandera; Thaer Khoury; Christine B Ambrosone; Song Yao
Journal:  Mol Oncol       Date:  2021-06-10       Impact factor: 6.603

10.  Immune cell infiltration landscape and immune marker molecular typing in preeclampsia.

Authors:  YiLin Meng; Chuang Li; Cai-Xia Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.